Relationships between cisplatin-induced adducts and DNA strand-breaks, mutation and recombination in vivo in somatic cells of Drosophila melanogaster, under different conditions of nucleotide excision repair

• Published in: Mutation research. Genetic toxicology and environmental mutagenesis 2012-01, Vol.741 (1), p.81-88
• Main Authors: García Sar, Daniel, Aguado, Leticia, Montes Bayón, María, Comendador, Miguel A., Blanco González, Elisa, Sanz-Medel, Alfredo, Sierra, Luisa María
• Format: Article
• Language: English
• Subjects: Chemotherapy; Cisplatin; Comet assay; DNA damage; Drosophila melanogaster; G monoadduct; G–G intrastrand cross-link; HPLC–ICP-MS; IDA; Insects; Mutation; NER; Pharmaceuticals; SMART; Tumors
• ISSN: 1383-5718; 1879-3592
• DOI: 10.1016/j.mrgentox.2011.11.005

Cisplatin is a chemotherapeutic drug widely used in the treatment of several tumours, but this chemotherapy presents problems in terms of side-effects and patient resistance. The detection and determination of cisplatin-induced adducts and the relationship with the physiological or clinical effects of this drug under different repair conditions could be a good measure to assess patient's response to such chemotherapy. A new methodological approach to detect and quantify cisplatin adducts by use of high-performance liquid chromatography with inductively coupled plasma mass-spectrometric detection (HPLC–ICP-MS) and isotope-dilution analysis (IDA), is evaluated for its application in vivo, under different repair conditions. This analysis is combined with the use of the Comet assay, which detects DNA strand-breaks, and the w/ w + SMART assay, which monitors induction of somatic mutation and recombination in Drosophila melanogaster in vivo under different conditions of nucleotide-excision repair. Results show that (i) cisplatin induces in Drosophila several adducts not detected in mammals. The two most abundant cisplatin-induced adducts, identified by electrospray-mass spectrometry as G monoadduct and G–G intrastrand cross-links, were quantified individually; (ii) cisplatin induces higher levels of G monoadducts and G–G cross-links in NER-proficient than in NER-deficient cells; (iii) the level of adducts correlates with their biological consequences, both in terms of DNA strand-breaks (tail-moment values), and of somatic mutation and recombination (frequency of mosaic eyes and clones in 10 4 cells), when the repair status is considered. This work demonstrates the validity and potential of the adduct detection and quantification methodology in vivo, and its use to correlate adducts with their genetic consequences.